HEADER PROTEIN BINDING 04-OCT-07 2VDB TITLE STRUCTURE OF HUMAN SERUM ALBUMIN WITH S-NAPROXEN AND THE GA MODULE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 30-608; COMPND 5 SYNONYM: HUMAN SERUM ALBUMIN; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PEPTOSTREPTOCOCCAL ALBUMIN-BINDING PROTEIN; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: RESIDUES 213-265; COMPND 10 SYNONYM: GA MODULE; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: SERUM; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: PEPTOSTREPTOCOCCUS MAGNUS; SOURCE 8 ORGANISM_TAXID: 1260; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS LIPID-BINDING, METAL-BINDING, PROTEIN BINDING, PEPTIDOGLYCAN-ANCHOR, KEYWDS 2 BACTERIAL ALBUMIN-BINDING, DISEASE MUTATION, THREE-HELIX BUNDLE, GA KEYWDS 3 MODULE, DRUG BINDING, GLYCOPROTEIN, CLEAVAGE ON PAIR OF BASIC KEYWDS 4 RESIDUES, HUMAN SERUM ALBUMIN, SECRETED, NAPROXEN, CELL WALL, KEYWDS 5 GLYCATION EXPDTA X-RAY DIFFRACTION AUTHOR S.LEJON,J.F.CRAMER,P.A.NORDBERG REVDAT 5 23-OCT-24 2VDB 1 REMARK REVDAT 4 13-DEC-23 2VDB 1 REMARK REVDAT 3 13-JUL-11 2VDB 1 VERSN REVDAT 2 24-FEB-09 2VDB 1 VERSN REVDAT 1 26-FEB-08 2VDB 0 JRNL AUTH S.LEJON,J.F.CRAMER,P.A.NORDBERG JRNL TITL STRUCTURAL BASIS FOR THE BINDING OF NAPROXEN TO HUMAN SERUM JRNL TITL 2 ALBUMIN IN THE PRESENCE OF FATTY ACIDS AND THE GA MODULE. JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 64 64 2008 JRNL REFN ESSN 1744-3091 JRNL PMID 18259051 JRNL DOI 10.1107/S174430910706770X REMARK 2 REMARK 2 RESOLUTION. 2.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 94.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 24846 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.236 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1273 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 11.17 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 94.92 REMARK 3 REFLECTION IN BIN (WORKING SET) : 264 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 17 REMARK 3 BIN FREE R VALUE : 0.2280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4783 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 58.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.89100 REMARK 3 B22 (A**2) : 2.07600 REMARK 3 B33 (A**2) : -0.16400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.19800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.661 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.329 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.272 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.495 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4977 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6742 ; 1.371 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 626 ; 6.058 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 211 ;37.133 ;24.502 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 792 ;17.692 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;19.905 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 764 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3732 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2553 ; 0.265 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3461 ; 0.320 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 210 ; 0.199 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.255 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 1 ; 0.033 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3230 ; 0.863 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5024 ; 1.385 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1949 ; 0.865 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1718 ; 1.277 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 6 A 170 REMARK 3 ORIGIN FOR THE GROUP (A): 10.3350 -10.8830 16.4890 REMARK 3 T TENSOR REMARK 3 T11: -.1415 T22: .5611 REMARK 3 T33: .2279 T12: .0693 REMARK 3 T13: -.1121 T23: -.4095 REMARK 3 L TENSOR REMARK 3 L11: 6.4372 L22: 3.2271 REMARK 3 L33: 8.1325 L12: -.4552 REMARK 3 L13: -1.2825 L23: -1.2228 REMARK 3 S TENSOR REMARK 3 S11: -.1309 S12: 1.6769 S13: -.8563 REMARK 3 S21: -.1877 S22: .0016 S23: .4563 REMARK 3 S31: -.0970 S32: -1.4555 S33: .1293 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 174 A 280 REMARK 3 ORIGIN FOR THE GROUP (A): 32.2810 -5.6380 20.2570 REMARK 3 T TENSOR REMARK 3 T11: -.1340 T22: -.1739 REMARK 3 T33: -.2653 T12: .0340 REMARK 3 T13: -.0567 T23: -.1208 REMARK 3 L TENSOR REMARK 3 L11: 7.1002 L22: .9258 REMARK 3 L33: 2.4077 L12: -.3121 REMARK 3 L13: -2.0175 L23: -.0102 REMARK 3 S TENSOR REMARK 3 S11: -.0173 S12: .5464 S13: .0641 REMARK 3 S21: .0620 S22: -.1379 S23: .4003 REMARK 3 S31: -.0172 S32: -.6088 S33: .1553 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 283 A 336 REMARK 3 ORIGIN FOR THE GROUP (A): 49.0430 -1.1750 21.3460 REMARK 3 T TENSOR REMARK 3 T11: -.2538 T22: -.3336 REMARK 3 T33: -.3979 T12: .0603 REMARK 3 T13: -.0426 T23: -.0263 REMARK 3 L TENSOR REMARK 3 L11: 6.9941 L22: 3.5297 REMARK 3 L33: 2.9487 L12: -.5307 REMARK 3 L13: .5848 L23: .9063 REMARK 3 S TENSOR REMARK 3 S11: -.0637 S12: -.0170 S13: .3423 REMARK 3 S21: -.0756 S22: -.1392 S23: -.4597 REMARK 3 S31: -.1641 S32: .1218 S33: .2030 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 343 A 466 REMARK 3 ORIGIN FOR THE GROUP (A): 35.4270 9.4530 35.9410 REMARK 3 T TENSOR REMARK 3 T11: -.1314 T22: -.2486 REMARK 3 T33: -.0678 T12: .0078 REMARK 3 T13: -.0958 T23: -.1444 REMARK 3 L TENSOR REMARK 3 L11: 10.4763 L22: 1.3131 REMARK 3 L33: 7.3764 L12: -3.7031 REMARK 3 L13: -8.0493 L23: 2.7746 REMARK 3 S TENSOR REMARK 3 S11: -.1985 S12: -.3060 S13: .3633 REMARK 3 S21: .1054 S22: .0528 S23: -.0255 REMARK 3 S31: .2316 S32: .0074 S33: .1456 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 471 A 584 REMARK 3 ORIGIN FOR THE GROUP (A): 15.1560 14.4300 50.0490 REMARK 3 T TENSOR REMARK 3 T11: -.0968 T22: .0395 REMARK 3 T33: -.0470 T12: -.0660 REMARK 3 T13: -.0259 T23: -.1285 REMARK 3 L TENSOR REMARK 3 L11: 9.8225 L22: 2.4588 REMARK 3 L33: 4.5748 L12: -.1534 REMARK 3 L13: -4.1628 L23: .5872 REMARK 3 S TENSOR REMARK 3 S11: .4977 S12: -.5824 S13: .0586 REMARK 3 S21: .2891 S22: -.3594 S23: .2859 REMARK 3 S31: -.0886 S32: -.5510 S33: -.1382 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 53 REMARK 3 ORIGIN FOR THE GROUP (A): 53.2560 -5.0860 5.2500 REMARK 3 T TENSOR REMARK 3 T11: -.1361 T22: .1313 REMARK 3 T33: -.3681 T12: .0349 REMARK 3 T13: .0323 T23: .0484 REMARK 3 L TENSOR REMARK 3 L11: 5.1466 L22: 9.5034 REMARK 3 L33: 5.4194 L12: -1.3985 REMARK 3 L13: -.8852 L23: 1.0871 REMARK 3 S TENSOR REMARK 3 S11: .1728 S12: 1.3579 S13: .2960 REMARK 3 S21: -.5846 S22: -.1146 S23: -.4366 REMARK 3 S31: -.0345 S32: .2623 S33: -.0581 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VDB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1290033945. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : DIAMOND(111), GE(220) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, TRUNCATE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24847 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 80.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.330 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.52 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.69 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.950 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRIES 1E7E AND 1TF0 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26-32% PEG 3350, 50 MM POTASSIUM REMARK 280 PHOSPHATE, 0.1 M AMMONIUM PHOSPHATE/POTASSIUM PHOSPHATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 95.25350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.73100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 95.25350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.73100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 81 REMARK 465 GLU A 82 REMARK 465 THR A 83 REMARK 465 TYR A 84 REMARK 465 GLY A 85 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 12 CG CD CE NZ REMARK 470 GLU A 16 CG CD OE1 OE2 REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 LEU A 31 CG CD1 CD2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 GLU A 45 CG CD OE1 OE2 REMARK 470 GLU A 48 CG CD OE1 OE2 REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 THR A 52 OG1 CG2 REMARK 470 VAL A 54 CG1 CG2 REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 GLU A 57 CG CD OE1 OE2 REMARK 470 SER A 58 OG REMARK 470 GLU A 60 CG CD OE1 OE2 REMARK 470 ASN A 61 CG OD1 ND2 REMARK 470 LYS A 64 CG CD CE NZ REMARK 470 ASP A 72 CG OD1 OD2 REMARK 470 LYS A 73 CG CD CE NZ REMARK 470 LEU A 74 CG CD1 CD2 REMARK 470 GLU A 86 CG CD OE1 OE2 REMARK 470 MET A 87 CG SD CE REMARK 470 ASP A 89 CG OD1 OD2 REMARK 470 LYS A 93 CG CD CE NZ REMARK 470 GLN A 94 CG CD OE1 NE2 REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 GLU A 100 CG CD OE1 OE2 REMARK 470 GLN A 104 CG CD OE1 NE2 REMARK 470 ASP A 108 CG OD1 OD2 REMARK 470 ASP A 121 CG OD1 OD2 REMARK 470 ASP A 129 CG OD1 OD2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 LYS A 174 CD CE NZ REMARK 470 GLU A 244 CG CD OE1 OE2 REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 LYS A 262 CG CD CE NZ REMARK 470 LYS A 313 CG CD CE NZ REMARK 470 LYS A 359 CD CE NZ REMARK 470 GLU A 368 CG CD OE1 OE2 REMARK 470 LYS A 372 CG CD CE NZ REMARK 470 LYS A 378 CD CE NZ REMARK 470 LYS A 389 CG CD CE NZ REMARK 470 GLU A 393 CD OE1 OE2 REMARK 470 GLU A 396 CG CD OE1 OE2 REMARK 470 LYS A 402 CD CE NZ REMARK 470 LYS A 432 CD CE NZ REMARK 470 LYS A 436 CG CD CE NZ REMARK 470 LYS A 439 CG CD CE NZ REMARK 470 LYS A 444 CG CD CE NZ REMARK 470 GLU A 465 CG CD OE1 OE2 REMARK 470 LYS A 466 CD CE NZ REMARK 470 LEU A 481 CG CD1 CD2 REMARK 470 GLU A 505 CG CD OE1 OE2 REMARK 470 GLU A 520 CG CD OE1 OE2 REMARK 470 GLU A 542 CG CD OE1 OE2 REMARK 470 LYS A 545 CG CD CE NZ REMARK 470 GLU A 556 CG CD OE1 OE2 REMARK 470 LYS A 557 CD CE NZ REMARK 470 LYS A 560 CG CD CE NZ REMARK 470 ASP A 562 CG OD1 OD2 REMARK 470 GLU A 565 CG CD OE1 OE2 REMARK 470 LYS A 574 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE A 395 O LEU A 398 2.05 REMARK 500 NZ LYS A 225 O GLU A 297 2.13 REMARK 500 OE2 GLU A 383 NH1 ARG A 485 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP A 63 CG ASP A 63 OD1 0.496 REMARK 500 ASP A 63 CG ASP A 63 OD2 0.326 REMARK 500 SER A 65 CB SER A 65 OG 0.107 REMARK 500 THR A 76 CB THR A 76 CG2 0.221 REMARK 500 THR A 76 C THR A 76 O 0.167 REMARK 500 ALA A 78 C ALA A 78 O 0.196 REMARK 500 ALA A 78 C THR A 79 N 0.176 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 63 CB - CG - OD2 ANGL. DEV. = -10.5 DEGREES REMARK 500 ARG A 336 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 ARG A 337 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 16 -68.97 4.52 REMARK 500 GLU A 48 8.24 52.25 REMARK 500 ALA A 50 177.41 -55.45 REMARK 500 LYS A 51 -4.96 55.43 REMARK 500 THR A 52 -60.88 -127.61 REMARK 500 CYS A 53 -19.07 -47.39 REMARK 500 ASN A 61 -9.50 63.25 REMARK 500 LYS A 64 150.68 -48.61 REMARK 500 LEU A 74 44.71 -73.54 REMARK 500 CYS A 75 22.58 -153.80 REMARK 500 VAL A 77 134.29 156.98 REMARK 500 ALA A 78 -67.80 -28.07 REMARK 500 CYS A 91 -5.10 70.08 REMARK 500 GLN A 94 70.07 -101.56 REMARK 500 GLU A 95 161.18 56.37 REMARK 500 PRO A 96 115.75 -7.23 REMARK 500 GLU A 97 4.68 101.04 REMARK 500 ARG A 98 -56.24 -135.89 REMARK 500 GLU A 100 -9.63 -59.95 REMARK 500 CYS A 101 -74.44 -78.59 REMARK 500 ARG A 114 105.82 -52.31 REMARK 500 ASN A 130 118.71 -175.37 REMARK 500 TYR A 150 120.27 -39.44 REMARK 500 PHE A 223 62.26 -115.75 REMARK 500 SER A 272 131.33 -176.47 REMARK 500 VAL A 310 -53.17 -133.09 REMARK 500 ALA A 322 84.42 -159.44 REMARK 500 CYS A 360 -8.03 -143.99 REMARK 500 CYS A 361 1.40 -62.31 REMARK 500 GLU A 442 1.73 -52.18 REMARK 500 LYS A 466 45.11 -85.88 REMARK 500 THR A 467 51.81 165.10 REMARK 500 VAL A 469 -33.48 -153.78 REMARK 500 ASN A 503 103.14 45.47 REMARK 500 LYS A 541 -15.24 73.96 REMARK 500 CYS A 559 -17.32 81.09 REMARK 500 ALA A 582 -11.62 89.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 96 GLU A 97 -145.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 (NPX): S-NAPROXEN. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1585 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1586 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1587 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1588 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1589 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1590 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NPS A1591 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BM0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E7A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL REMARK 900 ANESTHETIC PROPOFOL REMARK 900 RELATED ID: 1E7E RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID REMARK 900 RELATED ID: 1E7G RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1GNI RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC REMARK 900 ACID) REMARK 900 RELATED ID: 1H9Z RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HA2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HK1 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- REMARK 900 THYRONINE) REMARK 900 RELATED ID: 1HK4 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- REMARK 900 THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) REMARK 900 RELATED ID: 1HK5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) REMARK 900 RELATED ID: 1TF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMANSERUM ALBUMIN REMARK 900 RELATED ID: 1UOR RELATED DB: PDB REMARK 900 X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED REMARK 900 BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE REMARK 900 MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1YSX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMINCOMPLEXED TO REMARK 900 AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2 REMARK 900 RELATED ID: 2BX8 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE REMARK 900 RELATED ID: 2BXA RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY -4-METHYL-5-PROPYL-2- REMARK 900 FURANPROPANOIC ACID ( CMPF) REMARK 900 RELATED ID: 2BXB RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE REMARK 900 RELATED ID: 2BXC RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE REMARK 900 RELATED ID: 2BXD RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN REMARK 900 RELATED ID: 2BXI RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE REMARK 900 RELATED ID: 2BXO RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE REMARK 900 RELATED ID: 2BXQ RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , PHENYLBUTAZONE AND REMARK 900 INDOMETHACIN REMARK 900 RELATED ID: 1AO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1BJ5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1BKE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- REMARK 900 IODOBENZOIC ACID REMARK 900 RELATED ID: 1E78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE REMARK 900 RELATED ID: 1E7C RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL REMARK 900 ANESTHETIC HALOTHANE REMARK 900 RELATED ID: 1E7F RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID REMARK 900 RELATED ID: 1E7H RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID REMARK 900 RELATED ID: 1E7I RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID REMARK 900 RELATED ID: 1GNJ RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC REMARK 900 ACID (ARACHIDONIC ACID) REMARK 900 RELATED ID: 1HK2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) REMARK 900 RELATED ID: 1HK3 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) REMARK 900 RELATED ID: 1N5U RELATED DB: PDB REMARK 900 X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME REMARK 900 RELATED ID: 1O9X RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC REMARK 900 ACID) AND HEMIN REMARK 900 RELATED ID: 2BXE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL REMARK 900 RELATED ID: 2BXF RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM REMARK 900 RELATED ID: 2BXG RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN REMARK 900 RELATED ID: 2BXH RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE REMARK 900 RELATED ID: 2BXK RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , AZAPROPAZONE AND REMARK 900 INDOMETHACIN REMARK 900 RELATED ID: 2BXL RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5- REMARK 900 DIIODOSALICYLIC ACID REMARK 900 RELATED ID: 2BXM RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN REMARK 900 RELATED ID: 2BXN RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE REMARK 900 RELATED ID: 2BXP RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE REMARK 900 RELATED ID: 2ESG RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULINIGA1 AND REMARK 900 HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1GAB RELATED DB: PDB REMARK 900 STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR , 20 STRUCTURES REMARK 900 RELATED ID: 1PRB RELATED DB: PDB REMARK 900 STRUCTURE OF AN ALBUMIN-BINDING DOMAIN, NMR , MINIMIZED AVERAGE REMARK 900 STRUCTURE REMARK 900 RELATED ID: 2J5Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GA MODULE FROM F .MAGNA REMARK 999 REMARK 999 SEQUENCE REMARK 999 STRUCTURE CONTAINS RESIDUES 30 TO 608 OF THE UNIPROT ENTRY, REMARK 999 CORRESPONDING TO RESIDUES 6 TO 584 IN THE BIOLOGICAL REMARK 999 MOLECULE. REMARK 999 THE GA MODULE IS RESIDUES 213 TO 265 OF THE UNIPROT ENTRY. REMARK 999 THE STRUCTURE ALSO CONTAINS 2 N-TERMINAL TAG RESIDUES. DBREF 2VDB A 6 584 UNP P02768 ALBU_HUMAN 30 608 DBREF 2VDB B -1 0 PDB 2VDB 2VDB -1 0 DBREF 2VDB B 1 53 UNP Q51911 PAB_PEPMA 213 265 SEQRES 1 A 579 GLU VAL ALA HIS ARG PHE LYS ASP LEU GLY GLU GLU ASN SEQRES 2 A 579 PHE LYS ALA LEU VAL LEU ILE ALA PHE ALA GLN TYR LEU SEQRES 3 A 579 GLN GLN CYS PRO PHE GLU ASP HIS VAL LYS LEU VAL ASN SEQRES 4 A 579 GLU VAL THR GLU PHE ALA LYS THR CYS VAL ALA ASP GLU SEQRES 5 A 579 SER ALA GLU ASN CYS ASP LYS SER LEU HIS THR LEU PHE SEQRES 6 A 579 GLY ASP LYS LEU CYS THR VAL ALA THR LEU ARG GLU THR SEQRES 7 A 579 TYR GLY GLU MET ALA ASP CYS CYS ALA LYS GLN GLU PRO SEQRES 8 A 579 GLU ARG ASN GLU CYS PHE LEU GLN HIS LYS ASP ASP ASN SEQRES 9 A 579 PRO ASN LEU PRO ARG LEU VAL ARG PRO GLU VAL ASP VAL SEQRES 10 A 579 MET CYS THR ALA PHE HIS ASP ASN GLU GLU THR PHE LEU SEQRES 11 A 579 LYS LYS TYR LEU TYR GLU ILE ALA ARG ARG HIS PRO TYR SEQRES 12 A 579 PHE TYR ALA PRO GLU LEU LEU PHE PHE ALA LYS ARG TYR SEQRES 13 A 579 LYS ALA ALA PHE THR GLU CYS CYS GLN ALA ALA ASP LYS SEQRES 14 A 579 ALA ALA CYS LEU LEU PRO LYS LEU ASP GLU LEU ARG ASP SEQRES 15 A 579 GLU GLY LYS ALA SER SER ALA LYS GLN ARG LEU LYS CYS SEQRES 16 A 579 ALA SER LEU GLN LYS PHE GLY GLU ARG ALA PHE LYS ALA SEQRES 17 A 579 TRP ALA VAL ALA ARG LEU SER GLN ARG PHE PRO LYS ALA SEQRES 18 A 579 GLU PHE ALA GLU VAL SER LYS LEU VAL THR ASP LEU THR SEQRES 19 A 579 LYS VAL HIS THR GLU CYS CYS HIS GLY ASP LEU LEU GLU SEQRES 20 A 579 CYS ALA ASP ASP ARG ALA ASP LEU ALA LYS TYR ILE CYS SEQRES 21 A 579 GLU ASN GLN ASP SER ILE SER SER LYS LEU LYS GLU CYS SEQRES 22 A 579 CYS GLU LYS PRO LEU LEU GLU LYS SER HIS CYS ILE ALA SEQRES 23 A 579 GLU VAL GLU ASN ASP GLU MET PRO ALA ASP LEU PRO SER SEQRES 24 A 579 LEU ALA ALA ASP PHE VAL GLU SER LYS ASP VAL CYS LYS SEQRES 25 A 579 ASN TYR ALA GLU ALA LYS ASP VAL PHE LEU GLY MET PHE SEQRES 26 A 579 LEU TYR GLU TYR ALA ARG ARG HIS PRO ASP TYR SER VAL SEQRES 27 A 579 VAL LEU LEU LEU ARG LEU ALA LYS THR TYR GLU THR THR SEQRES 28 A 579 LEU GLU LYS CYS CYS ALA ALA ALA ASP PRO HIS GLU CYS SEQRES 29 A 579 TYR ALA LYS VAL PHE ASP GLU PHE LYS PRO LEU VAL GLU SEQRES 30 A 579 GLU PRO GLN ASN LEU ILE LYS GLN ASN CYS GLU LEU PHE SEQRES 31 A 579 GLU GLN LEU GLY GLU TYR LYS PHE GLN ASN ALA LEU LEU SEQRES 32 A 579 VAL ARG TYR THR LYS LYS VAL PRO GLN VAL SER THR PRO SEQRES 33 A 579 THR LEU VAL GLU VAL SER ARG ASN LEU GLY LYS VAL GLY SEQRES 34 A 579 SER LYS CYS CYS LYS HIS PRO GLU ALA LYS ARG MET PRO SEQRES 35 A 579 CYS ALA GLU ASP TYR LEU SER VAL VAL LEU ASN GLN LEU SEQRES 36 A 579 CYS VAL LEU HIS GLU LYS THR PRO VAL SER ASP ARG VAL SEQRES 37 A 579 THR LYS CYS CYS THR GLU SER LEU VAL ASN ARG ARG PRO SEQRES 38 A 579 CYS PHE SER ALA LEU GLU VAL ASP GLU THR TYR VAL PRO SEQRES 39 A 579 LYS GLU PHE ASN ALA GLU THR PHE THR PHE HIS ALA ASP SEQRES 40 A 579 ILE CYS THR LEU SER GLU LYS GLU ARG GLN ILE LYS LYS SEQRES 41 A 579 GLN THR ALA LEU VAL GLU LEU VAL LYS HIS LYS PRO LYS SEQRES 42 A 579 ALA THR LYS GLU GLN LEU LYS ALA VAL MET ASP ASP PHE SEQRES 43 A 579 ALA ALA PHE VAL GLU LYS CYS CYS LYS ALA ASP ASP LYS SEQRES 44 A 579 GLU THR CYS PHE ALA GLU GLU GLY LYS LYS LEU VAL ALA SEQRES 45 A 579 ALA SER GLN ALA ALA LEU GLY SEQRES 1 B 55 HIS MET THR ILE ASP GLN TRP LEU LEU LYS ASN ALA LYS SEQRES 2 B 55 GLU ASP ALA ILE ALA GLU LEU LYS LYS ALA GLY ILE THR SEQRES 3 B 55 SER ASP PHE TYR PHE ASN ALA ILE ASN LYS ALA LYS THR SEQRES 4 B 55 VAL GLU GLU VAL ASN ALA LEU LYS ASN GLU ILE LEU LYS SEQRES 5 B 55 ALA HIS ALA HET DKA A1585 12 HET DKA A1586 12 HET DKA A1587 12 HET DKA A1588 12 HET DKA A1589 12 HET DKA A1590 12 HET NPS A1591 17 HETNAM DKA DECANOIC ACID HETNAM NPS (2S)-2-(6-METHOXYNAPHTHALEN-2-YL)PROPANOIC ACID HETSYN NPS NAPROXEN FORMUL 3 DKA 6(C10 H20 O2) FORMUL 9 NPS C14 H14 O3 HELIX 1 1 GLU A 6 GLY A 15 1 10 HELIX 2 2 GLU A 16 LEU A 31 1 16 HELIX 3 3 PRO A 35 GLU A 45 1 11 HELIX 4 4 SER A 65 LEU A 74 1 10 HELIX 5 5 GLU A 86 CYS A 90 5 5 HELIX 6 6 ASN A 99 LYS A 106 1 8 HELIX 7 7 GLU A 119 ASN A 130 1 12 HELIX 8 8 ASN A 130 HIS A 146 1 17 HELIX 9 9 TYR A 150 CYS A 169 1 20 HELIX 10 10 LYS A 174 PHE A 206 1 33 HELIX 11 11 PHE A 206 PHE A 223 1 18 HELIX 12 12 GLU A 227 CYS A 246 1 20 HELIX 13 13 ASP A 249 ASN A 267 1 19 HELIX 14 14 ASN A 267 SER A 272 1 6 HELIX 15 15 LEU A 275 GLU A 280 1 6 HELIX 16 16 PRO A 282 GLU A 292 1 11 HELIX 17 17 LEU A 305 VAL A 310 1 6 HELIX 18 18 ASP A 314 ALA A 322 1 9 HELIX 19 19 ALA A 322 HIS A 338 1 17 HELIX 20 20 SER A 342 CYS A 361 1 20 HELIX 21 21 ASP A 365 ALA A 371 1 7 HELIX 22 22 LYS A 372 ASP A 375 5 4 HELIX 23 23 GLU A 376 LEU A 398 1 23 HELIX 24 24 GLY A 399 VAL A 415 1 17 HELIX 25 25 SER A 419 LYS A 439 1 21 HELIX 26 26 LYS A 444 LYS A 466 1 23 HELIX 27 27 SER A 470 THR A 478 1 9 HELIX 28 28 SER A 480 ALA A 490 1 11 HELIX 29 29 ASN A 503 THR A 508 5 6 HELIX 30 30 HIS A 510 LEU A 516 5 7 HELIX 31 31 SER A 517 LYS A 536 1 20 HELIX 32 32 GLU A 542 CYS A 558 1 17 HELIX 33 33 ASP A 563 ALA A 581 1 19 HELIX 34 34 THR B 1 LYS B 20 1 20 HELIX 35 35 SER B 25 ALA B 35 1 11 HELIX 36 36 THR B 37 ALA B 53 1 17 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.47 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.04 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.05 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.04 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.04 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.02 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.08 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.05 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.04 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.04 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.09 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.03 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.05 SITE 1 AC1 6 ARG A 117 TYR A 138 ILE A 142 TYR A 161 SITE 2 AC1 6 ARG A 186 NPS A1591 SITE 1 AC2 8 ARG A 10 TYR A 150 LEU A 251 ALA A 254 SITE 2 AC2 8 ARG A 257 ALA A 258 LEU A 283 SER A 287 SITE 1 AC3 6 SER A 342 VAL A 344 ARG A 348 LEU A 387 SITE 2 AC3 6 ARG A 485 DKA A1588 SITE 1 AC4 6 ARG A 410 TYR A 411 LEU A 460 PHE A 488 SITE 2 AC4 6 SER A 489 DKA A1587 SITE 1 AC5 2 ASP A 324 GLU B 47 SITE 1 AC6 5 LEU A 238 LEU A 260 SER A 287 ILE A 290 SITE 2 AC6 5 ALA A 291 SITE 1 AC7 8 HIS A 146 PHE A 149 LEU A 154 PHE A 157 SITE 2 AC7 8 TYR A 161 ARG A 186 GLY A 189 DKA A1585 CRYST1 190.507 49.462 79.933 90.00 93.00 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005249 0.000000 0.000275 0.00000 SCALE2 0.000000 0.020218 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012528 0.00000